Inflammation: Friend or foe of muscle remodelling in COPD?

European Respiratory Journal

Volumn 30, Issue 4, 2007, Pages 605-607

  Langen, R C J ^a   Schols, A M W J ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLIXIMAB; TUMOR NECROSIS FACTOR ALPHA;

CHRONIC OBSTRUCTIVE LUNG DISEASE; CYTOKINE RELEASE; EDITORIAL; HUMAN; INFLAMMATION; LEG MUSCLE; MUSCLE BIOPSY; MUSCLE CONTRACTILITY; MYOPATHY; NONHUMAN; PRIORITY JOURNAL; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; ANIMAL; BIOLOGICAL MODEL; BIOPSY; METABOLISM; NOTE; PATHOLOGY; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION; SMOOTH MUSCLE;

ANIMALS; BIOPSY; HUMANS; INFLAMMATION; MODELS, BIOLOGICAL; MUSCLE, SMOOTH; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 38449104697     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.00098107     Document Type: Editorial

References (28)

1. Montes de Oca M, Torres SH, De Sanctis J, Mata A, Hernández N, Tálamo C. Skeletal muscle inflammation and nitric oxide in patients with COPD. Eur Respir J 2005; 26: 390-397.
2. Rabinovich RA, Figueras M, Ardite E, et al. Increased tumour necrosis factor-α plasma levels during moderate-intensity exercise in COPD patients. Eur Respir J 2003; 21: 789-794.
3. Koechlin C, Maltais F, Saey D, et al. Hypoxaemia enhances peripheral muscle oxidative stress in chronic obstructive pulmonary disease. Thorax 2005; 60: 834-841.
4. Vogiatzis I, Stratakos G, Simoes DD, et al. Effects of rehabilitative exercise on peripheral muscle TNF-α, IL-6, IGF-I and MyoD expression in COPD patients. Thorax 2007; [Epub ahead of print PMID: 17573449].
5. Gea J, Orozco-Levi M, Barreiro E, Ferrer A, Broquetas J. Structural and functional changes in the skeletal muscles of COPD patients: the "compartments" theory. Monaldi Arch Chest Dis 2001; 56: 214-224.
6. Doucet M, Debigaré R, Joanisse DR, et al. Adaptation of the diaphragm and the vastus lateralis in mild-to-moderate COPD. Eur Respir J 2004; 24: 971-979.
7. Casadevall C, Coronell C, Ramírez-Sarmiento AL, et al. Upregulation of pro-inflammatory cytokines in the intercostal muscles of COPD patients. Eur Respir J 2007; 30: 701-707.
8. Wilcox PG, Wakai Y, Walley KR, Cooper DJ, Road J. Tumor necrosis factor alpha decreases in vivo diaphragm contractility in dogs. Am J Respir Crit Care Med 1994; 150: 1368-1373.
9. Li X, Moody MR, Engel D, et al. Cardiac-specific overexpression of tumor necrosis factor-α causes oxidative stress and contractile dysfunction in mouse diaphragm. Circulation 2000; 102: 1690-1696.
10. Reid MB, Lannergren J, Westerblad H. Respiratory and limb muscle weakness induced by tumor necrosis factor-α: involvement of muscle myofilaments. Am J Respir Crit Care Med 2002; 166: 479-484.
11. Gosselin LE, Barkley JE, Spencer MJ, McCormick KM, Farkas GA. Ventilatory dysfunction in mdx mice: impact of tumor necrosis factor-α deletion. Muscle Nerve 2003; 28: 336-343.
12. Demoule A, Divangahi M, Yahiaoui L, et al. Endotoxin triggers nuclear factor-κB-dependent up-regulation of multiple proinflammatory genes in the diaphragm. Am J Respir Crit Care Med 2006; 174: 646-653.
13. Kuru S, Inukai A, Kato T, Liang Y, Kimura S, Sobue G. Expression of tumor necrosis factor-α in regenerating muscle fibers in inflammatory and non-inflammatory myopathies. Acta Neuropathol (Berl) 2003; 105: 217-224.
14. Zador E, Mendler L, Takacs V, de Bleecker J, Wuytack F. Regenerating soleus and extensor digitorum longus muscles of the rat show elevated levels of TNF-α and its receptors, TNFR-60 and TNFR-80. Muscle Nerve 2001; 24: 1058-1067.
15. Collins RA, Grounds MD. The role of tumor necrosis factor-α (TNF-α) in skeletal muscle regeneration. Studies in TNF-α(-/-) and TNF-α(-/-)/LT-α(-/-) mice. J Histochem Cytochem 2001; 49: 989-1001.
16. Chen SE, Jin B, Li YP. TNF-α regulates myogenesis and muscle regeneration by activating p38 MAPK. Am J Physiol Cell Physiol 2007; 292: C1660-C1671.
17. Chen SE, Gerken E, Zhang Y, et al. Role of TNF-(α) signaling in regeneration of cardiotoxin-injured muscle. Am J Physiol Cell Physiol 2005; 289: C1179-C1187.
18. Guttridge DC, Mayo MW, Madrid LV, Wang CY, Baldwin AS Jr. NF-κB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Science 2000; 289: 2363-2366.
19. Langen RC, Schols AM, Kelders MC, Wouters EF, Janssen-Heininger YM. Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor-κB. FASEB J 2001; 15: 1169-1180.
20. Langen RC, Van Der Velden JL, Schols AM, Kelders MC, Wouters EF, Janssen-Heininger YM. Tumor necrosis factor-α inhibits myogenic differentiation through MyoD protein destabilization. FASEB J 2004; 18: 227-237.
21. Langen RC, Schols AM, Kelders MC, van der Velden JL, Wouters EF, Janssen-Heininger YM. Muscle wasting and impaired muscle regeneration in a murine model of chronic pulmonary inflammation. Am J Respir Cell Mol Biol 2006; 35: 689-696.
22. Peterson JM, Feeback KD, Baas JH, Pizza FX. Tumor necrosis factor-α promotes the accumulation of neutrophils and macrophages in skeletal muscle. J Appl Physiol 2006; 101: 1394-1399.
23. Torrente Y, El Fahime E, Caron NJ, et al. Tumor necrosis factor-α (TNF-α) stimulates chemotactic response in mouse myogenic cells. Cell Transplant 2003; 12: 91-100.
24. Buck M, Chojkier M. Muscle wasting and dedifferentiation induced by oxidative stress in a murine model of cachexia is prevented by inhibitors of nitric oxide synthesis and antioxidants. EMBO J 1996; 15: 1753-1765.
25. Cai D, Frantz JD, Tawa NE Jr, et al. IKKκ/NF-κB activation causes severe muscle wasting inmice. Cell 2004; 119: 285-298.
26. Ottenheijm CA, Heunks LM, Sieck GC, et al. Diaphragm dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 172: 200-205.
27. Agusti A, Morla M, Sauleda J, Saus C, Busquets X. NF-κB activation and iNOS upregulation in skeletal muscle of patients with COPD and low body weight. Thorax 2004; 59: 483-487.
28. Rennard SI, Fogarty C, Kelsen S, et al. The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007; 175: 926-934.